Krystal Biotech KRYS Ratios (2016-2026)

NASDAQ KRYS
$322.17 -3.25 (-1.00%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Krystal Biotech Quarterly Ratios

Periods 37 quarters
Latest Jun 2026

Krystal Biotech reported a gross margin of 94.60% and a net margin of 45.94% for the quarter ended Jun 2026. These financial ratios cover 37 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2016 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
97.39%93.19%94.66%91.45%92.03%94.57%94.30%92.54%95.64%93.85%94.57%94.60%
EBT Margin
943.75%25.29%2.06%22.82%35.51%53.35%49.43%48.70%49.05%47.74%52.79%55.43%
EBIT Margin
-303.80%7.71%-14.75%12.18%26.80%45.41%41.10%41.02%42.30%41.33%46.12%49.00%
EBITDA Margin
-294.14%11.28%-11.60%14.75%28.35%46.94%42.70%42.38%43.74%42.76%47.43%50.17%
Operating Margin
-303.80%7.71%-14.75%12.18%26.80%45.41%41.10%41.02%42.30%41.33%46.12%49.00%
Net Margin
943.75%20.62%2.06%22.15%32.42%49.91%40.51%39.91%81.15%47.99%48.05%45.94%
FCF Margin
-268.90%-21.54%32.29%-7.54%68.95%57.12%28.08%52.92%38.81%70.37%62.92%59.74%
Efficiency
Inventory AverageInventory Avg.
6.13M9.01M11.61M15.38M22.54M28.23M30.49M34.34M39.05M41.56M44.10M
Assets AverageAssets Avg.
447.33M538.70M621.58M609.10M588.85M567.41M545.15M607.94M737.19M804.35M835.83M885.48M949.99M1,019.08M1,065.13M1,106.41M1,189.24M1,286.94M1,365.38M1,448.81M
Equity AverageEquity Avg.
413.39M500.91M571.07M553.87M549.98M531.50M505.90M571.34M704.53M767.29M788.94M819.07M862.37M916.11M965.53M1,012.66M1,089.26M1,178.72M1,248.14M1,317.93M
Invested CapitalInvested Cap.
Asset Utilization RatioAsset Util.
-0.010.010.060.110.190.250.290.310.320.310.300.310.30
Leverage & Solvency
Interest Coverage RatioInterest Cover
Debt Ratio
Times Interest Earned
Valuation
Price to EarningsP/E
320.4488.8049.7799.9550.5942.0327.1025.7235.1433.7945.56
Price to SalesP/S
382.2669.0952.8731.7021.6715.5215.6311.0713.7118.4918.2224.97
Price to BookP/B
2.842.973.113.013.313.914.225.034.334.506.356.285.914.775.293.824.505.905.968.09
Enterprise Value
817.95M1,325.20M1,271.13M1,259.55M1,397.54M1,661.83M1,714.86M2,806.74M2,708.51M2,970.90M4,537.73M4,712.51M4,646.31M3,913.35M4,593.64M3,294.32M4,385.48M6,369.20M6,780.76M10,154.31M
EV to EBIT
168.3359.5442.2723.6227.6939.4937.9451.35
EV to EBITDA
138.1454.6240.0922.7326.7638.1636.7649.87
Market Capitalization
1,161.05M1,763.30M1,705.76M1,685.12M1,791.96M2,041.00M2,065.24M3,284.26M3,270.58M3,503.08M5,075.99M5,272.12M5,234.64M4,510.87M5,210.49M3,976.31M5,116.55M7,197.00M7,604.17M10,999.95M
Price to FCFP/FCF
90.1637.8540.2921.4430.9038.1032.0342.67
EV to FCF
80.0232.8435.5217.7626.4833.7128.5639.39
EV to CFO
73.3531.7133.1716.8624.8931.7127.0937.29
Return Ratios
Return on Sales [ROS]ROS
-303.80%7.71%-14.75%12.18%26.80%45.41%41.10%41.02%42.30%41.33%46.12%49.00%
Return on Capital Employed [ROCE]ROCE
-13.81%-13.31%-18.56%-20.27%-23.59%-26.96%-28.19%-26.21%-20.81%-14.21%-8.56%-2.56%3.21%7.17%11.02%13.68%14.43%13.62%14.21%14.97%
Return on Assets [ROA]ROA
-13.04%-12.95%-16.75%-19.13%-22.47%-25.59%-26.38%-24.39%-4.89%0.92%6.84%11.96%5.51%8.75%11.64%13.26%16.73%15.91%16.48%16.67%
Return on Equity [ROE]ROE
-14.11%-13.93%-18.24%-21.03%-24.06%-27.32%-28.42%-25.95%-5.12%0.97%7.25%12.93%6.07%9.73%12.84%14.49%18.26%17.37%18.03%18.32%

Krystal Biotech Ratios API

Pull Krystal Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KRYS&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY